BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10197592)

  • 1. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
    Chen JJ; Silver D; Cantor S; Livingston DM; Scully R
    Cancer Res; 1999 Apr; 59(7 Suppl):1752s-1756s. PubMed ID: 10197592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
    Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
    Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.
    Chen J; Silver DP; Walpita D; Cantor SB; Gazdar AF; Tomlinson G; Couch FJ; Weber BL; Ashley T; Livingston DM; Scully R
    Mol Cell; 1998 Sep; 2(3):317-28. PubMed ID: 9774970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is hereditary predisposition to breast cancer linked to BRCA1 a disease of response to genotoxic lesions?].
    Feunteun J
    C R Seances Soc Biol Fil; 1998; 192(2):235-40. PubMed ID: 9759367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1, BRCA2 and their possible function in DNA damage response.
    Kote-Jarai Z; Eeles RA
    Br J Cancer; 1999 Dec; 81(7):1099-102. PubMed ID: 10584867
    [No Abstract]   [Full Text] [Related]  

  • 6. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.
    Cousineau I; Abaji C; Belmaaza A
    Cancer Res; 2005 Dec; 65(24):11384-91. PubMed ID: 16357146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
    Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
    Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
    Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common nonsense mutations in RAD52.
    Bell DW; Wahrer DC; Kang DH; MacMahon MS; FitzGerald MG; Ishioka C; Isselbacher KJ; Krainer M; Haber DA
    Cancer Res; 1999 Aug; 59(16):3883-8. PubMed ID: 10463575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells.
    Le Page F; Randrianarison V; Marot D; Cabannes J; Perricaudet M; Feunteun J; Sarasin A
    Cancer Res; 2000 Oct; 60(19):5548-52. PubMed ID: 11034101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer. BRCA2 enters the fray.
    Wilson JH; Elledge SJ
    Science; 2002 Sep; 297(5588):1822-3. PubMed ID: 12228708
    [No Abstract]   [Full Text] [Related]  

  • 12. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.
    O'Donovan PJ; Livingston DM
    Carcinogenesis; 2010 Jun; 31(6):961-7. PubMed ID: 20400477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Rad51 alteration in patients with bilateral breast cancer.
    Kato M; Yano K; Matsuo F; Saito H; Katagiri T; Kurumizaka H; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nagawa H; Nakamura Y; Miki Y
    J Hum Genet; 2000; 45(3):133-7. PubMed ID: 10807537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.
    Abaji C; Cousineau I; Belmaaza A
    Cancer Res; 2005 May; 65(10):4117-25. PubMed ID: 15899802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BRCA1/BRCA2/Rad51 complex is a prognostic and predictive factor in early breast cancer.
    Söderlund K; Skoog L; Fornander T; Askmalm MS
    Radiother Oncol; 2007 Sep; 84(3):242-51. PubMed ID: 17707537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer genetics. BRCA1 and BRCA2: the main genes for disease predisposition].
    Ruiz-Flores P; Calderón-Garcidueñas AL; Barrera-Saldaña HA
    Rev Invest Clin; 2001; 53(1):46-64. PubMed ID: 11332051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple possible sites of BRCA2 interacting with DNA repair protein RAD51.
    Katagiri T; Saito H; Shinohara A; Ogawa H; Kamada N; Nakamura Y; Miki Y
    Genes Chromosomes Cancer; 1998 Mar; 21(3):217-22. PubMed ID: 9523196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2.
    Wang H; Zeng ZC; Bui TA; DiBiase SJ; Qin W; Xia F; Powell SN; Iliakis G
    Cancer Res; 2001 Jan; 61(1):270-7. PubMed ID: 11196174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families.
    Rapakko K; Heikkinen K; Karppinen SM; Winqvist R
    Cancer Lett; 2006 May; 236(1):142-7. PubMed ID: 16005565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.